2013 ACCF/AHA guide- line for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362 425. 4.3.2. Electrophysiological Study for VA S4.3.2-1. Buxton AE, Lee KL, DiCarlo L, et al. Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sud- den death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 2000;342:1937 45. S4.3.2-2. Buxton AE, Lee KL, Hafley GE, et al. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease: an analysis of patients enrolled in the multi- center unsustained tachycardia trial. Circulation. 2002;106:2466 72. S4.3.2-3. Costantini O, Hohnloser SH, Kirk MM, et al. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alter- nans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol. 2009;53:471 9. S4.3.2-4. Bourke JP, Richards DA, Ross DL, et al. Routine programmed electri- cal stimulation in survivors of acute myocardial infarction for predic- tion of spontaneous ventricular tachyarrhythmias during follow-up: results, optimal stimulation protocol and cost-effective screening. J Am Coll Cardiol. 1991;18:780 8. S4.3.2-5. Bailey JJ, Berson AS, Handelsman H, et al. Utility of current risk stratification tests for predicting major arrhythmic events after myo- cardial infarction. J Am Coll Cardiol. 2001;38:1902 11. S4.3.2-6. Schmitt C, Barthel P, Ndrepepa G, et al. Value of programmed ven- tricular stimulation for prophylactic internal cardioverter-defibrillator implantation in postinfarction patients preselected by noninvasive risk stratifiers. J Am Coll Cardiol. 2001;37:1901 7. S4.3.2-7. Hilfiker G, Schoenenberger AW, Erne P, et al. Utility of electro- physiological studies to predict arrhythmic events. World J Cardiol. 2015;7:344 50. S4.3.2-8. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 